Transchem Limited Board Approves Rs. 461 Crore Warrant Issue and Capital Increase

Transchem Limited's Board approved issuing up to 6.15 crore warrants worth Rs. 461.25 crore to non-promoter investors including Bakkt Opco Holdings LLC, Mr. Pishu Chainani, JVS Holdings LLP, and Mr. Dhawal Mehta at Rs. 75 per warrant. The company also approved increasing authorized share capital from Rs. 30 crore to Rs. 75 crore and authorized investments/loans up to Rs. 250 crore, with shareholder approval sought through EGM on December 20, 2025.

Transchem Limited Approves Q2 FY2026 Results and Plans 100% Acquisition of Greshma Shares & Stocks Limited

Transchem Limited's Board approved unaudited financial results for the quarter and half-year ended September 30, 2025, showing net profit of ₹67.92 crores for Q2 and ₹167.25 crores for H1. The company also granted in-principle approval to acquire 100% equity in Greshma Shares & Stocks Limited, a stock broking and financial services company with annual turnover of ₹11.32 crores and net worth of ₹15.89 crores as of March 2025. The acquisition involves purchasing 1,55,16,000 shares for cash consideration, subject to due diligence and regulatory approvals from SEBI, stock exchanges, and depositories. Upon completion, GSSL will become a wholly-owned subsidiary, allowing Transchem to diversify into comprehensive financial services including equity and derivatives trading on BSE and NSE. The acquisition is expected to be completed within 3 months of entering the non-binding term sheet.

Transchem Limited Board Approves Strategic Shift to Financial Services Business

Transchem Limited's Board of Directors approved the adoption of new Articles of Association and Memorandum of Association on September 23, 2025. The company is pivoting its core business from natural products, herbal, medicinal, and pharmaceutical products to the financial services sector. The new business objectives include stockbroking in shares, commodities, and currencies, portfolio management, investment advisory services, fund management, and acting as a depository participant. The company plans to leverage technology including artificial intelligence and machine learning to enhance operations. All changes are subject to shareholder approval at an upcoming Extraordinary General Meeting. The Board believes this strategic shift will unlock significant value for shareholders and position the company for sustainable long-term growth in the financial sector.